Towa Pharmaceutical Co., Ltd.

TSE:4553.T

2991 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 16,1734,60522,24618,72820,70918,8869,8337,2379,90315,2068,7029,3109,7339,4357,334.0476,244.0344,575.6084,363.5932,277.3693,083.066
Depreciation & Amortization 17,88819,40910,95410,4258,2858,3408,1737,9807,3295,7245,4074,9092,6371,8731,787.1941,853.041,474.0141,301.546950.903739.63
Deferred Income Tax 00000000000000000000
Stock Based Compensation 00000000000000000000
Change In Working Capital -26,944-13,747-3,102-11,559233-1,553-1,546-4,496-8,485-7,836-2,929-2,135-4,286-2,986-992.259-1,780.124-1,278.758-2,187.459-914.704-1,615.119
Accounts Receivables -15,523-1,592441-4,5442,776-4,153-4,240-421-3,134-3,164-2,289-74900000000
Inventory -6,288-18,496-7,950-9,707-4,301-1,6163,192-2,439-6,913-7,503-2,963-2,371-3,819-2,638-1,405.9-79.231-1,150.818-1,195.329-887.138-577.837
Accounts Payables -10,5096,5543,6752,4511,8264,659-967-1,3711,54300000000000
Other Working Capital 5,376-213732241-68-443-4,738-2,057-1,572-33334236-467-348413.641-1,700.893-127.94-992.13-27.566-1,037.282
Other Non Cash Items 69,191-7,723-7,969-5,586-10,063-6,6712,770-526-5,015-5,057-3,036-3,439-4,705-2,583-1,571.135-1,845.299-1,056.535-829.063-1,274.453-1,074.318
Operating Cash Flow 8,2122,54422,12912,00819,16419,00219,23010,1953,7328,0378,1448,6453,3795,7396,557.8474,471.6513,714.3292,648.6171,039.1151,133.259
Investing Activities:
Investments In Property Plant And Equipment -39,325-30,469-13,576-9,879-4,670-11,354-15,373-21,168-14,117-13,706-8,218-10,678-9,379-8,898-2,502.395-2,843.917-2,022.043-1,175.182-2,308.552-3,134.101
Acquisitions Net -1,569-1,484-45,405-894-37,710-207-2992-562-384-178-140-343-3540-8.02518.981.813-183.199245.25
Purchases Of Investments -50-301-1-894-7,663-25,418-29,969-29,915-22,498-6,500-11,500-10,294-155-3470-50-1,422.487-2,675.811-2,172.97-300
Sales Maturities Of Investments 0341889412,52333,99024,53928,51216,49811,5008,23310,30315616161.465404.1521,831.1831,602.4582,119.3521,346.534
Other Investing Activites 5501,936-7651,673-2,021-1,0051,0093631,647860363-4891,2391,729-4,939.34822.66413.70418.046201.46229.162
Investing Cash Flow -40,394-30,284-59,729-9,100-39,541-3,994-20,093-22,206-19,032-8,230-11,300-11,298-8,482-7,854-7,280.278-2,475.13-1,180.663-2,228.676-2,343.907-1,813.155
Financing Activities:
Debt Repayment -38,338-12,268-7,181-17,745-6,396-4,249-2,681-2,033-2,505-2,971-2,937-2,565-700000-750-5000
Common Stock Issued 002101200037,2740003,493000002,313.3310
Common Stock Repurchased 0056,137020,200000-5,042000-6270-1.3-0.858-1.501-0.764-0.335-0.611
Dividends Paid -2,952-3,100-2,411-2,166-2,067-1,559-1,557-1,558-1,755-1,275-1,275-1,233-1,285-1,072-775.192-771.708-772.532-428.919-690.409-319.246
Other Financing Activities 2432,849-2620,095-14,9998,9083,499-24,4847,7416,591-25,2923,998.750-0.0010-0.0010
Financing Cash Flow 35,40717,48146,54018411,748-8094,670-9227,9702383,5292,7938794,2203,222.258-772.566-1,524.034-479.6831,622.586-319.857
Other Information:
Effect Of Forex Changes On Cash 2,1671,68597576168994359168964848725146-9-1616.44130.307-35.11967.73635.16135.945
Net Change In Cash 5,393-8,5739,9154,202-7,93915,1414,399-11,41413,318533690187-4,2332,0902,516.2691,254.262974.5127.994352.956-963.808
Cash At End Of Period 29,65024,25732,83022,91518,71326,65211,5117,11218,5265,2084,6753,9853,7988,0315,941.6553,425.3862,171.1241,196.6121,188.618835.662